Skip to content
Yatharth Hospital logo

Yatharth Hospital & Trauma Care Services

YATHARTH NSE
₹1,027.90 +46.05 (+4.69%)
P/E
54.68
View as Markdown
MCP
Close 4 Nov 2026 ₹1,027.90 +233.95 +29.5% 1Y
Start ₹793.95

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
12.90%
Debt to Equity
0.15
EPS (TTM)
₹18.80
Book Value
₹194.67
Market Cap
—
P/E (TTM)
54.68
P/B
5.28
ROE
10.20%
Dividend Yield
0.05%
EBITDA
₹318 Cr
52W High
₹1,184.00
52W Low
₹538.25
Day Range
₹988.85 – ₹1,036.00
Volume
7,05,934

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Yatharth Hospital peer comparison
Apollo Hospitals
₹8,599.5059.18₹1,22,850 Cr13.040.24%21.20%17.40%₹26,430 Cr₹2,171 Cr
Max Healthcare Institute
₹927.1561.89₹89,301 Cr7.960.22%14.70%14.70%₹8,712 Cr₹1,457 Cr
Manipal Health Enterprises
₹667.2088.96₹86,479 Cr5.340.00%6.64%8.30%₹11,400 Cr₹906 Cr
Aster DM Healthcare
₹719.55117.00₹59,927 Cr14.910.44%11.30%11.60%₹4,876 Cr₹363 Cr
Fortis Healthcare
₹790.6556.96₹59,706 Cr6.030.13%11.20%13.40%₹9,506 Cr₹1,070 Cr
Narayana Hrudayalaya
₹1,931.5048.36₹39,090 Cr7.890.24%20.50%15.50%₹9,072 Cr₹816 Cr
Global Health
₹1,402.0067.76₹37,618 Cr9.520.04%15.20%17.40%₹4,683 Cr₹552 Cr
Yatharth Hospital (this company)
₹1,027.9054.68₹9,925 Cr5.280.05%10.20%12.90%₹1,334 Cr₹174 Cr
Median 8 companies₹977.5360.54₹59,817 Cr7.930.18%13.00%14.05%₹8,892 Cr₹861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

54 Average

Data confidence 100/100

Category scores

Quality
49
Average
Returns, margins, earnings quality 22% weight
Valuation
30
Poor
Cheap vs sector & own history 24% weight
Growth
94
Strong
Sales & profit trajectory 9% weight
Financial Health
64
Good
Solvency, leverage, coverage 9% weight
Momentum
61
Good
Trend strength, vol-adjusted 12% weight
Ownership
68
Strong
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 56.9% CAGR over last 5 years
  • Company's working capital requirements have reduced from 101 days to 80.1 days

Weaknesses

2
  • Company has a low return on equity of 12.0% over last 3 years.
  • Promoter holding has decreased over last 3 years: -10.5%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish2512
OscillatorsNeutral252
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
59.10
Neutral
MACD (12,26,9)
−11.99
Bullish
SMA (50)
1,002.52
Bullish
SMA (200)
819.94
Bullish

As of

Analyst Rating

Based on 2 analysts
BUY100%

2 of 2 analysts rate Buy, 0 Hold, 0 Sell.

As of

BUY
2
100%
HOLD
0
0%
SELL
0
0%

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y+41.21%
3Y+36.17%
1Y+36.23%
TTM+43.91%

Net profit

Net profit growth by window
5Y+53.42%
3Y+37.08%
1Y+29.77%
TTM+22.54%

Operating cash flow

Operating cash flow growth by window
5Y+36.04%
3Y+47.41%
1Y+56.49%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y−6.36 pp
3Y−2.97 pp
1Y−0.69 pp
TTM−1.61 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹71.00 Cr
Mar 2018₹78.00 Cr
Mar 2019₹91.00 Cr
Mar 2020₹136 Cr
Mar 2021₹215 Cr
Mar 2022₹375 Cr
Mar 2023₹478 Cr
Mar 2024₹635 Cr
Mar 2025₹886 Cr
Mar 2026₹1,207 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹3.00 Cr
Mar 2018₹6.00 Cr
Mar 2019₹4.00 Cr
Mar 2020−₹2.00 Cr
Mar 2021₹20.00 Cr
Mar 2022₹44.00 Cr
Mar 2023₹66.00 Cr
Mar 2024₹114 Cr
Mar 2025₹131 Cr
Mar 2026₹170 Cr

Analyst Forecasts

Forecast For
FY27 consensus · EBITDA
₹420 Cr +32.0% vs FY26
Reported High Mean Low

AI Analysis — Bull vs Bear

Generated 6 Jul 2026
AI opinion · based on fundamentals
Risk high

Yatharth Hospital & Trauma Care Services is a mid-cap healthcare company with a market cap of Rs 8,296 Cr trading at a PE of 49x. The company has delivered strong revenue growth of 41% CAGR over 5 years and profit growth of 57% CAGR over the same period, though its return on equity has moderated to 10% in the last year from a 5-year average of 14%.

Bull Case 8
  • Exceptional 5-year compounded profit growth of 57% CAGR demonstrates strong operating leverage and scaling ability
  • Compounded sales growth of 41% CAGR over 5 years and 36% over 3 years indicates sustained revenue momentum in a growing healthcare market
  • TTM revenue growth remains robust at 40%, showing no meaningful deceleration from the 3-year trend of 36%
  • Working capital days have improved from 102 days to 80.1 days, reflecting better operational efficiency and cash conversion
  • Stock has delivered 50% returns over the past 1 year, indicating strong market confidence in the growth trajectory
  • TTM profit growth of 36% remains healthy and broadly in line with the 3-year CAGR of 39%
  • Company is expected to deliver a good quarter ahead, suggesting near-term earnings visibility remains intact
  • Price-to-book ratio of 4.68x is not extreme for a high-growth healthcare platform, suggesting the market is pricing in continued compounding
Bear Case 7
  • Return on equity has declined from a 5-year average of 14% to just 10% in the last year, signaling potential dilution of capital efficiency as the company expands
  • Zero dividend yield despite repeated profitability means shareholders rely entirely on capital appreciation for returns
  • 3-year ROE of only 12% is below the 15%+ threshold typically expected for a company commanding a 49x PE multiple
  • Debt-to-equity ratio is not disclosed, creating uncertainty about the leverage profile funding the aggressive expansion
  • Profit growth has decelerated from 57% CAGR over 5 years to 39% over 3 years and 36% TTM, suggesting the rate of earnings expansion may be plateauing
  • Limited listed history with no available 3-year, 5-year, or 10-year stock CAGR data makes it difficult to assess long-term shareholder value creation
  • At Rs 8,296 Cr market cap with a 49x PE, any quarterly miss or margin compression could trigger a sharp de-rating given the premium valuation

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

121d ago

TL;DR: Yatharth Hospital is in expansion mode with a Rs 100 Cr asset acquisition in Gurugram signaling capacity growth in the NCR market. Promoter holdings remain unencumbered, reflecting financial discipline. No visible headwinds from recent news flow. The trend appears constructive with the company investing in growth while maintaining a clean balance sheet posture.

Positives 1
  • Rs 100 Cr Gurugram acquisition Jun 12

    Yatharth Hospital completed acquisition of Gurugram assets worth Rs 100 Cr through subsidiary AKS Medical, expanding its geographic footprint in the NCR region.

Neutral 1
  • No promoter share encumbrance Jun 30

    Promoters held 5,37,62,672 shares as on March 31, 2026 with zero encumbrance during FY26, indicating no pledging pressure on promoter holdings.

Quarterly Results

₹ Cr
YATHARTH quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
155
171
167
178
212
218
219
232
258
279
320
342
393
431
Expenses
113
126
120
131
158
163
164
175
193
215
246
262
301
329
Operating Profit
41
46
46
47
54
55
55
57
64
65
74
80
92
102
OPM %
27%
27%
28%
26%
25%
25%
25%
25%
25%
23%
23%
23%
23%
24%
Other Income
1
4
5
6
4
3
4
5
9
9
8
7
4
5
Interest
6
3
0
0
3
2
2
1
0
0
1
5
7
8
Depreciation
7
7
8
8
11
16
17
13
15
19
24
30
28
33
PBT
29
40
44
44
43
40
40
49
59
55
57
52
61
66
Tax %
35%
30%
33%
13%
29%
23%
24%
20%
28%
25%
25%
14%
26%
26%
Net Profit
19
28
29
38
30
31
30
39
42
41
43
45
45
48
EPS (₹)
2.91
3.21
3.44
4.47
3.54
3.61
3.16
4.02
4.36
4.28
4.71
4.93
4.88
—

Sep 2026: from the results filed on 3 Nov 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
YATHARTH profit and loss, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
71
78
91
136
215
375
478
635
886
1,207
1,334
Expenses
53
60
71
98
147
263
343
453
655
902
1,024
Operating Profit
18
18
20
38
68
112
135
182
230
305
310
OPM %
25%
24%
22%
28%
32%
30%
28%
29%
26%
25%
23%
Other Income
0
0
0
0
1
2
3
16
11
25
29
Interest
6
5
7
20
20
23
23
11
12
19
13
Depreciation
7
6
8
21
21
28
28
29
57
88
101
PBT
5
8
5
−2
28
63
88
157
172
224
225
Tax %
41%
23%
21%
−18%
30%
30%
25%
27%
24%
24%
—
Net Profit
3
6
4
−2
20
44
66
114
131
170
174
EPS (₹)
2.21
3.75
2.43
−0.79
11.09
6.74
10.04
13.33
13.55
18.2
18.8
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
YATHARTH balance sheet, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
14
16
16
16
16
66
66
86
96
96
Reserves
29
41
39
38
56
51
117
788
1,509
1,684
Borrowings
85
125
175
194
193
264
267
85
12
264
Other Liabilities
10
11
26
39
43
45
36
60
114
218
Total Liabilities
138
193
257
287
309
426
486
1,019
1,731
2,262
Fixed Assets
54
53
164
189
251
303
299
442
605
1,250
CWIP
64
110
65
62
0
0
0
0
222
102
Investments
0
0
0
0
0
0
0
0
74
2
Other Assets
20
30
27
36
58
123
187
577
829
909
Total Assets
138
193
257
287
309
426
486
1,019
1,731
2,262

Cash Flow

₹ Cr
YATHARTH cash flow, annual, ₹ crore
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
25
17
17
39
44
60
64
−3
131
205
Investing
−50
−51
−78
−43
−21
−52
−20
−226
−388
−598
Financing
26
43
47
5
−19
−1
−18
304
509
254
Net Cash Flow
1
9
−13
1
3
7
26
75
253
−140
Free Cash Flow
24
16
−60
−4
24
21
44
−96
−171
−112
CFO/OP
148
103
99
109
67
65
75
22
68
94

Ratios

YATHARTH financial ratios, annual
Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
58
44
48
45
62
83
82
131
124
113
Inventory Days
47
42
88
72
—
—
—
—
43
32
Days Payable
127
106
490
347
—
—
—
—
60
171
Cash Conversion Cycle
−22
−20
−354
−229
62
83
82
131
107
−26
Working Capital Days
44
29
−75
−89
−18
0
29
118
106
80
ROCE %
—
8%
6%
7%
18%
26%
27%
24%
14%
13%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Yatharth Hospital insights

63 extracted metrics across FY17–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 55.80%
  • Public 18.51%
  • DIIs 10.94%
  • Others 7.70%
  • FIIs 7.05%

9.59% of promoter holding pledged as of Sep 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Yatharth Hospital & Trauma Care Services

What does Yatharth Hospital & Trauma Care Services Ltd do?
Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.
Where is Yatharth Hospital & Trauma Care Services Ltd (YATHARTH) listed?
Yatharth Hospital & Trauma Care Services Ltd trades as YATHARTH on the NSE and under code 543950 on the BSE.
Which sector does Yatharth Hospital & Trauma Care Services Ltd belong to?
Yatharth Hospital & Trauma Care Services Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the PE ratio of Yatharth Hospital & Trauma Care Services Ltd?
Yatharth Hospital & Trauma Care Services Ltd trades at a PE ratio of 54.68 as of 4 Nov 2026, on earnings per share of ₹18.8, against a book value of ₹194.67 per share.
What is the 52-week high and low of Yatharth Hospital & Trauma Care Services Ltd?
Over the last 52 weeks Yatharth Hospital & Trauma Care Services Ltd has traded between ₹538.25 and ₹1,184 as of 4 Nov 2026.
Does Yatharth Hospital & Trauma Care Services Ltd pay dividends?
Yatharth Hospital & Trauma Care Services Ltd has a dividend yield of 0.05%.
What is the Return on Equity (ROE) of Yatharth Hospital & Trauma Care Services Ltd?
Yatharth Hospital & Trauma Care Services Ltd reported a return on equity of 10.20%. Its debt-to-equity ratio is 0.15.

Company Information

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.

Website yatharthhospitals.com
Listed 7 Aug 2023
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/YATHARTH.md for Yatharth Hospital & Trauma Care Services Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month